U.S. RESEARCH ROUNDUP-Camden Property Trust, Homology Medicines, Zuora
16/03/2020 07:47
March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Camden Property Trust, Homology Medicines and Zuora,
on Monday.
HIGHLIGHTS
* Camden Property Trust CPT.N : Evercore ISI raises to outperform from in line
* Clorox Co CLX.N : JP Morgan raises to overweight from underweight
* Homology Medicines Inc FIXX.O : Oppenheimer raises to outperform from perform
* Las Vegas Sands Corp LVS.N : Jefferies raises to buy from hold
* Rattler Midstream LP RTLR.O : RBC raises to outperform from sector perform
* Zuora Inc ZUO.N : Needham cuts to hold from buy
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* Adma Biologics Inc ADMA.O : Raymond James cuts target price to $9 from $11
* Aquestive Therapeutics Inc AQST.O : Wedbush cuts target price to $31 from $36
* Aspen Technology AZPN.O : JP Morgan raises to neutral from underweight
* Aspen Technology AZPN.O : JP Morgan cuts target price to $112 from $123
* Bank7 Corp BSVN.O : Piper Sandler cuts target price to $11 from $19
* Camden Property Trust CPT.N : Evercore ISI raises to outperform from in line
* Clorox Co CLX.N : JP Morgan raises to overweight from underweight
* Clorox Co CLX.N : JP Morgan raises target price to $185 from $153
* Diebold Nixdorf Inc DBD.N : JP Morgan cuts target price to $8 from $9
* Eiger Biopharmaceuticals Inc EIGR.O : Jefferies cuts target price to $24 from $27
* Flexion Therapeutics Inc FLXN.O : Raymond James cuts target price to $23 from $28
* Headhunter Group Plc HHR.O : Credit Suisse cuts target price to $23 from $26
* Hibbett Sports Inc HIBB.O : Susquehanna cuts target price to $24 from $36
* Homology Medicines Inc FIXX.O : Oppenheimer raises to outperform from perform
* Jabil Inc JBL.N : Citigroup cuts price target to $30 from $47
* Jabil Inc JBL.N : Raymond James cuts target price to $45 from $49
* Kosmos Energy KOS.N :RBC cuts to underperform from outperform; cuts TP to $1.10 from $7
* Las Vegas Sands Corp LVS.N : Jefferies raises to buy from hold
* Lexicon Pharmaceuticals Inc LXRX.O : Citigroup cuts price target to $2.3 from $4
* Lexicon Pharmaceuticals Inc LXRX.O : Wedbush cuts target price to $13 from $17
* Marathon Oil MRO.N : RBC cuts to sector perform from outperform; cuts TP to $9 from $12
* NGL Energy Partners LP NGL.N : RBC cuts to sector perform from outperform
* NGL Energy Partners LP NGL.N : RBC cuts target price to $5 from $15
* NN Inc NNBR.O : JP Morgan cuts target price to $7 from $13
* NN Inc NNBR.O : Keybanc cuts target price to $12 from $16
* Rattler Midstream LP RTLR.O : RBC raises to outperform from sector perform
* Rattler Midstream LP RTLR.O : RBC cuts target price to $11 from $20
* Standard Chartered Plc STAN.L : Citigroup raises to buy from neutral
* Standard Chartered Plc STAN.L : Citigroup cuts price target to 610p from 690p
* Teladoc Health Inc TDOC.N : Keybanc raises to overweight from sector weight
* Tilray Inc TLRY.O : MKM Partners cuts target price to $5 from $13
* Wec Energy Group Inc WEC.N : Evercore ISI raises to in line from underperform
* Western Midstream Partners LP WES.N : RBC cuts target price to $7 from $19
* Xerox Holdings Corp XRX.N : JP Morgan cuts target price to $33 from $39
* Y-Mabs Therapeutics Inc YMAB.O : JP Morgan cuts target price to $34 from $39
* Zuora Inc ZUO.N : Needham cuts to hold from buy
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))